Under the agreement, ISMP would operate as a wholly owned subsidiary of ECRI Institute. Together, the nonprofit organizations will work to make medication, medical devices and healthcare organizations safer for patients.
ISMP’s president, Michael Cohen, and executive vice president, Allen Vaida, PharmD, will continue to lead the organization. Three leaders from ECRI Institute, including CEO Marcus Schabacker, MD, PhD, will also join ISMP’s board of trustees.
The transaction is expected to close Jan. 2, 2020.
More articles on clinical leadership & infection control:
Vaping damage is ‘evil I haven’t seen before,’ Henry Ford lung transplant surgeon says
130+ patients, staff members potentially exposed to TB at Washington hospital
35,000 people die from drug-resistant infections annually, CDC says
